Research programme: vaccines - BioNet-Asia

Drug Profile

Research programme: vaccines - BioNet-Asia

Alternative Names: CRM197 conjugate vaccine - BioNet Asia; Human papilloma virus vaccine - BioNet Asia; Paediatric vaccine - BioNet Asia; Recombinant hepatitis B vaccione - BioNet Asia

Latest Information Update: 08 Sep 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator BioNet-Asia
  • Class Bacterial vaccines; Vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Unspecified
  • Research Diphtheria; Hepatitis B; Human papillomavirus infections

Most Recent Events

  • 31 Aug 2016 Early research in Diphtheria (Prevention) in Thailand (Parenteral) (BioNet Asia pipeline, August 2016)
  • 31 Aug 2016 Early research in Hepatitis B (Prevention) in Thailand (Parenteral) (BioNet Asia pipeline, August 2016)
  • 31 Aug 2016 Early research in Human papillomavirus infections (Prevention) in Thailand (Parenteral) (BioNet Asia pipeline, August 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top